Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US EPA bars neonicotinoid use extensions

The US EPA has written to the registrants of the neonicotinoid insecticides, clothianidin, dinotefuran, imidacloprid and thiamethoxam, to inform them that it is unlikely to approve new outdoor uses until additional data on bees have been submitted and pollinator risk assessments completed. The letter reiterates that the Agency has required pollinator hazard and exposure data under the registration review for neonicotinoids. It requires data on potential impacts on developing bees, oral exposure and bee colony health. In the absence of the new studies, the EPA does not believe it has sufficient information to support a determination that new outdoor uses would meet the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) registration standard. Until the data have been reviewed and risk assessments completed, the Agency is unlikely to be in a position to determine that such uses would avoid "unreasonable adverse effects on the environment", the EPA points out.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG022156

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel